Does cannabis interact with Apixaban?

**Medical Disclaimer: This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare provider before using cannabis with prescription medications.** Cannabis may potentially interact with apixaban (Eliquis), a direct oral anticoagulant used to prevent blood clots and stroke. While research is limited, several mechanisms suggest possible interactions that patients should discuss with their healthcare providers. **Potential Interaction Mechanisms:** Cannabinoids, particularly THC and CBD, are metabolized by cytochrome P450 enzymes (primarily CYP3A4 and CYP2C19), which also process apixaban. CBD can inhibit these enzymes, potentially increasing apixaban blood levels and bleeding risk. A 2020 study in the Journal of Clinical Medicine found that CBD can significantly affect drug metabolism through cytochrome P450 inhibition. **Clinical Considerations:** Apixaban already carries bleeding risks, with major bleeding occurring in 2.1% of patients annually according to clinical trials. Cannabis use might theoretically amplify these risks through enzyme inhibition or additive effects on platelet function. Some cannabinoids may affect platelet aggregation, though research remains inconclusive. **Current Evidence Gaps:** Direct studies on cannabis-apixaban interactions are extremely limited. Most available data comes from case reports and theoretical pharmacokinetic modeling. A 2021 systematic review in Current Drug Metabolism highlighted the need for more research on cannabis-anticoagulant interactions. **Recommendations:** 1. **Medical supervision:** Any cannabis use should be disclosed to prescribing physicians 2. **Monitoring:** Enhanced monitoring for bleeding signs may be warranted 3. **Timing considerations:** Some experts suggest spacing cannabis and apixaban administration 4. **Documentation:** Keep detailed records of cannabis use patterns and any unusual symptoms Patients using apixaban should never adjust their medication without medical supervision. The evolving legal cannabis landscape has created an urgent need for more definitive interaction studies. Healthcare providers increasingly recommend comprehensive medication reviews that include cannabis products to ensure patient safety.